Age group | Prevalence | Sensitivity | Specifity | ROC-area | LR+ | LR- | PPV | NPV |
---|---|---|---|---|---|---|---|---|
34-44 | 3.8 (2.4-5.5) | 75 (53.3-90.2) | 92.2 (89.8-94.2) | .836 (.747-.925) | 9.61 (6.73-13.7) | .271 (.136-.542) | 27.3 (17–39.6) | 99 (97.7-99.6) |
45-54 | 6.2 (4.5-8.2) | 86.7 (73.2-94.9) | 89.9 (87.2-92.1) | .883 (.832-.935) | 8.62 (6.7-11.1) | .148 (.070-.312) | 36.1 (27.1-45.9) | 99 (97.9-99.6) |
55-64 | 6 (4.4-8.0) | 76.1 (61.2-87.4) | 84.9 (82.1-87.5) | .805 (.741-.869) | 5.05 (3.98-6.41) | .282 (.168-.472) | 24.5 (17.7-32.4) | 98.2 (96.8-99.1) |
65-74 | 7.9 (5.9-10.2) | 86.5 (74.2-94.4) | 85.4 (82.4-88.1) | .86 (.811-.909) | 5.93 (4.76-7.39) | .158 (.0791-.314) | 33.6 (25.7-42.2) | 98.7 (97.3-99.5) |
75-85 | 10 (7.4-14.1) | 86.5 (71.2-95.5) | 83.3 (78.8-87.3) | .849 (.79-.909) | 5.19 (3.93-6.84) | .162 (.0717-.367) | 37.6 (27.4-48.8) | 98.1 (95.7-99.4) |
Female | 8.4 (7.1-9.8) | 81.6 (74.1-87.7) | 83.8 81.8-85.6) | .827 (.973-.861) | 5.04 (4.38-5.8) | .219 (.154-.313) | 31.5 (26.7-36.7) | 98 (97.1-98.7) |
Male | 4.5 (3.5 -5.6) | 85.3 (74.6-92.7) | 91.4 (89.8-92.8) | .883 (.84-.926) | 9.87 (8.13-12) | .161 (.0908-.285) | 31.5 (24.9-38.8) | 99.3 (98.6-99.6) |
Total | 6.5 (5.6-7.4) | 82.8 (77–87.7) | 87.5 (86.3-88.7) | .852 (.825-.879) | 6.65 (5.93-7.46) | .196 (.145-.265) | 31.5 (27.6-35.7) | 98.7 (98.1-99.1) |